Login to Your Account



Easing the Burden of HCV Treatment at EASL 2013

By Anette Breindl
Science Editor

Wednesday, April 24, 2013
Clinical trials marking progress toward a broad-acting, all-oral regimen for treating hepatitis C were reported in The New England Journal of Medicine and at the International Liver Congress of the European Association for the Study of the Liver (EASL) in Amsterdam, the Netherlands, this week.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription